[144] INTERFACE INC SEC Filing

Rhea-AI Filing Summary

Interface, Inc. reported a Form 144 notice for the proposed sale of 538 common shares held by an insider, valued at $14,308.11, with an approximate sale date of 10/09/2025 on NASDAQ. The shares were acquired on 03/04/2025 through the vesting of restricted stock under a registered compensation plan and were recorded as compensation when paid.

The filing also discloses a prior sale by the same person: 79,497 shares sold on 08/06/2025 for gross proceeds of $2,035,321.95. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. This notice documents routine insider liquidity following a recent vesting event and prior substantial share disposition.

Positive

• Securities were acquired via restricted stock vesting, indicating compensation alignment with shareholder interests
• Filer provided required attestation that no undisclosed material adverse information is known

Negative

• Recent substantial insider sale of 79,497 shares for $2,035,321.95 could signal significant insider liquidity

Insights

Insider Transactions Specialist

Small scheduled sale after restricted-stock vesting; prior large disposition noted.

The filing records a restricted-stock vesting event on 03/04/2025 resulting in 538 shares now proposed for sale with an aggregate market value of $14,308.11. This is a routine conversion of compensation into liquid shares and is being processed under Rule 144.

There is a material prior sale of 79,497 shares on 08/06/2025 for $2,035,321.95, which represents significant recent insider liquidity. Monitor short-term trading dates (10/09/2025) and the cumulative supply effect if additional insider sales occur within the same reporting window.

Corporate Governance Analyst

Transaction consistent with compensation realization; disclosure includes attestation about material information.

The notice states the shares were acquired as compensation and sold under Rule 144, which aligns with standard governance practices when executives convert equity awards. The signer affirms no undisclosed material adverse information about the company.

Investors may note the combination of a recent large sale and this smaller proposed sale when assessing insider selling patterns over the past months; tracking aggregate insider dispositions through public filings over the next 30–90 days can clarify whether this is isolated or part of a broader liquidity trend.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	538	14308.11	58361516	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2025	Restricted stock vesting under a registered plan	Issuer			538	03/04/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NIGEL STANSFIELD 1280 WEST PEACHTREE ST. NW ATLANTA GA 30309	Common	08/06/2025	79497	2035321.95

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by Interface, Inc. (TILE) disclose?

The Form 144 reports a proposed sale of 538 common shares (vested restricted stock) valued at $14,308.11, with an approximate sale date of 10/09/2025, and notes a prior sale of 79,497 shares on 08/06/2025 for $2,035,321.95.

How were the 538 shares acquired according to the filing?

The 538 shares were acquired on 03/04/2025 through restricted stock vesting under a registered plan and were recorded as compensation on 03/04/2025.

When is the proposed sale scheduled and on which exchange will it occur?

The proposed sale is approximately scheduled for 10/09/2025 and the filing lists NASDAQ as the securities exchange.

Who previously sold shares and what were the proceeds?

Nigel Stansfield sold 79,497 common shares on 08/06/2025 for gross proceeds of $2,035,321.95.

Does the filing state any undisclosed material adverse information?

No. The person signing the notice represents they do not know any material adverse information about the issuer that has not been publicly disclosed.